wellrank.ai
Sign In

How much is Ozempic per month without insurance and how do people afford it?

ClaudepricingCollected Aug 6, 2026, 09:42 UTC

Verbatim response from Claude

Ozempic Cost Without Insurance

Retail price: approximately $900–$1,000+ per month for a typical dose, which makes it genuinely unaffordable for most people out of pocket.


How People Afford It

Manufacturer Savings Programs

  • Novo Nordisk's Ozempic Savings Card – can bring costs down to as low as $25/month for eligible commercially insured patients (not for Medicare/Medicaid)

Compounding Pharmacies (controversial but popular)

  • Compounded semaglutide (same active ingredient) from pharmacies like Hims & Hers, Ro, or LifeMD has run $200–$400/month
  • ⚠️ The FDA has raised safety concerns, and availability is changing as shortages resolve

GoodRx & Discount Cards

  • GoodRx can reduce costs somewhat, though savings on brand-name Ozempic are limited

Mark Cuban's Cost Plus Drugs

  • Doesn't currently carry Ozempic but worth watching

Telehealth Weight Loss Programs

  • WeightWatchers Clinic, Noom Med, or Found sometimes offer better pricing bundled with care

Medicare/Medicaid

  • Coverage varies significantly by plan and diagnosis (diabetes vs. weight loss)

Bottom line: Most people either use the manufacturer coupon, compounded versions, or simply can't afford it long-term. It's a real accessibility issue.

Brands mentioned in this answer

More Ozempic answers

See all Ozempic rankings and answers →

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.